1. The Mystery of How Gut Bacterial Toxins Disrupt the Barrier

The human intestine harbors Bacteroides fragilis, a bacterium associated with increased colorectal cancer risk. While the pro‑carcinogenic B. fragilis toxin (BFT) has been recognized, the precise pathway by which the toxin attacks and destroys colonic epithelial cells has remained obscure.

2. CRISPR Screening Identifies the Entry Route: Claudin-4

The investigators employed genome‑wide CRISPR screening to interrogate thousands of genes simultaneously and trace the toxin’s receptor. They discovered that Claudin-4, a tight‑junction protein expressed on the surface of colonic epithelial cells, serves as the primary receptor for BFT. This receptor functions as a “gateway,” enabling the toxin to transmit its deleterious signal into the cell.

3. Destruction of E-cadherin: The Collapsing Intercellular Adhesive

Binding of BFT to Claudin-4 triggers a cascade that leads to the proteolytic cleavage of E-cadherin, the protein that mediates strong cell‑cell adhesion. Loss of this “natural glue” creates gaps in the epithelial barrier, permitting bacterial translocation and immune cell infiltration, which in turn provokes chronic inflammation. The sustained damage establishes a microenvironment conducive to colorectal carcinogenesis.

4. Future Implications and Outlook

Elucidation of this mechanism opens new avenues for colorectal cancer prevention. Therapeutic strategies that block Claudin-4 interaction or protect E-cadherin from degradation could preempt toxin‑driven tumorigenesis. Personalized interventions that manage high‑risk microbial factors are anticipated to become feasible in the near future.